Full Transcript: 3D Sys Q2 2026 Earnings Call

3D Systems (NYSE:DDD) reported second-quarter 2026 revenue of $94.6 million, up 1.4% year over year. Printer sales increased more than 45%, led by the DMP350 metal system, SLA825 polymer platform and MultiJet systems supporting its denture product line. Healthcare Solutions revenue rose 6.8%, driven by medtech metal-printer demand. Industrial revenue declined 3.7% as the company discontinued non-core products and customers replaced older systems, although aerospace and defense and data center infrastructure again posted strong double-digit growth. DMP350 sales increased roughly 90% year over year, while SLA825 sales rose approximately 125%. The company also received one of its largest industrial printer orders, driven by investment-casting patterns for next-generation reusable rocket engines. The NextDent 300, launched in late 2025, targets digital monolithic dentures. After FDA clearance and full EU MDR approval in the second quarter, 3D Systems expects installations at more than 100 dental labs by year-end. Those initial systems are expected to generate more than $2 million in annual recurring revenue at highly accretive gross margins. The opportunity includes more than 30 million U.S. denture wearers and nearly 4 million new dentures sold annually, with potential U.S. printer and consumables revenue exceeding $150 million annually. Further approvals are expected in Mexico, South America and parts of Asia over the next year. Semiconductor and high-performance computing revenue grew almost 30%, primarily through metal parts. Management expects parts manufacturing to increasingly support revenue and profitability as production scales. Capacity is expanding in Belgium and Colorado. 3D Systems also signed a Cooperative Research and Development Agreement with Savannah River National Laboratory covering materials, component design, manufacturing and AI optimization for nuclear fission and fusion applications. CEO Dr. Jeffrey Graves plans to step down. Management forecasts Q3 revenue of $96 million to $99 million and adjusted EBITDA of negative $3 million to negative $1 million. Key risks include adoption, execution, replacement-related disruption and sustained profitability.